The effect of botulinum toxin type A on full-face intense pulsed light treatment: A randomized, double-blind, split-face study

Dermatologic Surgery

Volumn 34, Issue 8, 2008, Pages 1062-1069

  Khoury, Jane G ^b   Saluja, Raminder ^b   Goldman, Mitchel P ^a,b  

^a La Jolla Spa MD   (United States)

^b Dermatology & Cosmetic Laser Associates of La Jolla   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; SODIUM CHLORIDE;

ADULT; ARTICLE; CONTROLLED STUDY; ERYTHEMA; FEMALE; HUMAN; HYPERPIGMENTATION; INTENSE PULSE LIGHT TREATMENT; PHOTOTHERAPY; PRIORITY JOURNAL; WRINKLE;

ADULT; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FACE; FEMALE; HUMANS; INJECTIONS; MIDDLE AGED; NEUROTOXINS; PHOTOTHERAPY; RHYTIDOPLASTY; TRETOQUINOL;

EID: 48449106686     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2008.34207.x     Document Type: Article

References (15)

1. Zimbler MS, Holds JB, Kokoska MS, et al. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Arch Fac Plast Surg 2001 3: 165 9.
2. Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg 2003 29: 802 9.
3. Goldman MP, Weiss RA, Weiss MA. Intense pulsed light as a nonablative approach to photoaging. Dermatol Surg 2005 31: 1179 87.
4. Goldberg DJ, Cutler KB. Nonablative treatment of rhytids with intense pulsed light. Lasers Surg Med 2000 26: 196 200.
5. Carruthers J, Carruthers A. The effect of full-face broadband light treatments alone and in combination with bilateral crow's feet botulinum toxin type A chemodenervation. Dermatol Surg 2004 30: 355 66.
6. Yuraitis M, Jacob CI. Botulinum toxin for the treatment of facial flushing. Dermatol Surg 2004 30: 102 4.
7. Kranendonk SK, Ferris LK, Obagi S. Re: botulinum toxin for the treatment of facial flushing. Dermatol Surg 2005 31: 491.
8. Ehrlich M, Rao J, Pabby A, et al. Improvement in the appearance of wrinkles with topical transforming growth factor B1 and l-ascorbic acid. Dermatol Surg 2006 32: 618 25.
9. Heckmann M, Breit S, Ceballos-Baumann A, et al. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol 1999 41: 987 90.
10. Arad-Cohen A, Blitzer A. Botulinum toxin treatment for symptomatic Frey's syndrome. Otolaryngol Head Neck Surg 2000 122: 237 40.
11. Hsu TS, Dover J, Arndt K. Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol 2004 140: 1351 4.
12. Sterodimas A, Nicolaou M, Paes TR. Successful use of botulinum toxin-A for the treatment of neck and anterior chest wall flushing. Clin Exp Dermatol 2003 28: 592 4.
13. Jacob CI. Reply to Kranendonk et al. Dermatol Surg 2005 31: 492.
14. Toyoda M, Nakamura M, Nakada K, et al. Neurogenic factors in photoaged skin. Br J Dermatol 2005 153: 13 22.
15. Bull HA, Hothersall J, Chowdhury N, et al. Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells. J Invest Dermatol 1996 106: 655 60.